ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/08/19 | 2,927 | 3,030 | 2,913 | 2,986 | +87 | +3% | 624,700 |
| 2021/08/18 | 2,850 | 2,928 | 2,849 | 2,899 | +24 | +0.8% | 431,400 |
| 2021/08/17 | 2,960 | 2,960 | 2,872 | 2,875 | -71 | -2.4% | 455,200 |
| 2021/08/16 | 2,983 | 3,000 | 2,910 | 2,946 | -47 | -1.6% | 436,300 |
| 2021/08/13 | 2,997 | 3,030 | 2,976 | 2,993 | -4 | -0.1% | 331,700 |
| 2021/08/12 | 2,988 | 3,055 | 2,985 | 2,997 | +17 | +0.6% | 438,900 |
| 2021/08/11 | 2,943 | 3,005 | 2,931 | 2,980 | +72 | +2.5% | 622,700 |
| 2021/08/10 | 2,906 | 2,953 | 2,889 | 2,908 | -4 | -0.1% | 443,600 |
| 2021/08/06 | 2,905 | 2,947 | 2,878 | 2,912 | -1 | ±0% | 388,300 |
| 2021/08/05 | 2,949 | 2,963 | 2,887 | 2,913 | -52 | -1.8% | 552,900 |
| 2021/08/04 | 2,999 | 3,020 | 2,958 | 2,965 | +6 | +0.2% | 495,600 |
| 2021/08/03 | 2,999 | 3,020 | 2,924 | 2,959 | -76 | -2.5% | 702,600 |
| 2021/08/02 | 3,065 | 3,065 | 2,983 | 3,035 | -50 | -1.6% | 796,600 |
| 2021/07/30 | 3,185 | 3,185 | 2,988 | 3,085 | -205 | -6.2% | 1,528,800 |
| 2021/07/29 | 3,315 | 3,340 | 3,280 | 3,290 | +10 | +0.3% | 416,600 |
| 2021/07/28 | 3,305 | 3,335 | 3,255 | 3,280 | -50 | -1.5% | 361,900 |
| 2021/07/27 | 3,360 | 3,360 | 3,310 | 3,330 | +15 | +0.5% | 251,300 |
| 2021/07/26 | 3,355 | 3,365 | 3,310 | 3,315 | ±0 | ±0% | 233,700 |
| 2021/07/21 | 3,365 | 3,365 | 3,300 | 3,315 | +5 | +0.2% | 207,700 |
| 2021/07/20 | 3,275 | 3,330 | 3,260 | 3,310 | ±0 | ±0% | 239,900 |
| 2021/07/19 | 3,315 | 3,365 | 3,300 | 3,310 | -5 | -0.2% | 279,900 |
| 2021/07/16 | 3,260 | 3,365 | 3,255 | 3,315 | +5 | +0.2% | 364,200 |
| 2021/07/15 | 3,385 | 3,405 | 3,305 | 3,310 | -95 | -2.8% | 394,700 |
| 2021/07/14 | 3,455 | 3,455 | 3,365 | 3,405 | -45 | -1.3% | 446,900 |
| 2021/07/13 | 3,590 | 3,600 | 3,410 | 3,450 | -210 | -5.7% | 990,500 |
| 2021/07/12 | 3,650 | 3,670 | 3,610 | 3,660 | +80 | +2.2% | 308,100 |
| 2021/07/09 | 3,560 | 3,590 | 3,515 | 3,580 | ±0 | ±0% | 449,800 |
| 2021/07/08 | 3,650 | 3,675 | 3,565 | 3,580 | -80 | -2.2% | 351,700 |
| 2021/07/07 | 3,645 | 3,680 | 3,625 | 3,660 | +15 | +0.4% | 367,800 |
| 2021/07/06 | 3,595 | 3,670 | 3,590 | 3,645 | +45 | +1.3% | 252,100 |
| 2021/07/05 | 3,630 | 3,670 | 3,595 | 3,600 | -30 | -0.8% | 319,900 |
| 2021/07/02 | 3,705 | 3,710 | 3,620 | 3,630 | -55 | -1.5% | 522,200 |
| 2021/07/01 | 3,710 | 3,715 | 3,630 | 3,685 | -55 | -1.5% | 475,000 |
| 2021/06/30 | 3,690 | 3,745 | 3,660 | 3,740 | +75 | +2% | 707,100 |
| 2021/06/29 | 3,635 | 3,680 | 3,615 | 3,665 | +60 | +1.7% | 595,400 |
| 2021/06/28 | 3,620 | 3,635 | 3,585 | 3,605 | -10 | -0.3% | 337,600 |
| 2021/06/25 | 3,625 | 3,635 | 3,590 | 3,615 | -20 | -0.6% | 386,700 |
| 2021/06/24 | 3,585 | 3,690 | 3,565 | 3,635 | +55 | +1.5% | 685,700 |
| 2021/06/23 | 3,565 | 3,635 | 3,550 | 3,580 | +30 | +0.8% | 476,700 |
| 2021/06/22 | 3,540 | 3,575 | 3,520 | 3,550 | +40 | +1.1% | 348,900 |
| 2021/06/21 | 3,510 | 3,530 | 3,445 | 3,510 | -70 | -2% | 452,800 |
| 2021/06/18 | 3,565 | 3,595 | 3,545 | 3,580 | +60 | +1.7% | 574,900 |
| 2021/06/17 | 3,550 | 3,550 | 3,455 | 3,520 | -5 | -0.1% | 327,600 |
| 2021/06/16 | 3,510 | 3,555 | 3,495 | 3,525 | -35 | -1% | 267,900 |
| 2021/06/15 | 3,560 | 3,575 | 3,515 | 3,560 | ±0 | ±0% | 365,200 |
| 2021/06/14 | 3,500 | 3,590 | 3,485 | 3,560 | +70 | +2% | 590,400 |
| 2021/06/11 | 3,435 | 3,490 | 3,415 | 3,490 | +90 | +2.6% | 572,400 |
| 2021/06/10 | 3,375 | 3,405 | 3,370 | 3,400 | +10 | +0.3% | 293,600 |
| 2021/06/09 | 3,380 | 3,420 | 3,350 | 3,390 | +30 | +0.9% | 470,400 |
| 2021/06/08 | 3,250 | 3,405 | 3,235 | 3,360 | +160 | +5% | 761,200 |
801～
850
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
